Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Rocket Pharmaceuticals
Pharma
Rocket nets $180M in priority review voucher sale
Rocket’s $180 million deal marks a slight cooling in the PRV market, which recently saw prices peak around $200 million.
Zoey Becker
Apr 28, 2026 11:16am
Rocket is priming a limited launch of its 1st gene therapy nod
Mar 27, 2026 10:25am
Rocket boosts preparations for launch with new commercial chief
Apr 8, 2025 11:21am
'Light up for Rare' once again brings bright colors to monuments
Feb 27, 2023 10:40am
'Light up for Rare' spotlights rare disease
Feb 28, 2022 8:45am
Rocket Pharma spurs more buildings to light up for Rare Disease
Feb 26, 2021 10:10am
